Evaluation of low dose Intrathecal Bupivacaine with dexmedetomidine

Evaluation of low dose Intrathecal Bupivacaine with dexmedetomidine in Geriatric Patients Undergoing Traumatic Hip Surgeries

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202403633859291

Enrollment

Registered

2024-03-13

Start date

2024-02-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Group I

Group II

Group III

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: elderly patients (>65 years) either gender American Society of Anesthesiologists status I and II patients undergoing proximal femoral fractures fixation under spinal anesthesia

Exclusion criteria

Exclusion criteria: age less than 65 years American Society of Anesthesiologists (ASA) physical status class III or more Contraindication to spinal anaesthesia: peripheral neuropathy coagulopathy spinal deformity infection at the injection site known hypersensitivity to bupivacaine or dexmedetomidine

Design outcomes

Primary

Measure	Time frame
time to 1st dose rescue analgesia	—

Secondary

Measure	Time frame
sensory level block, two segment regression, hemodynamic stability and dose of vasopressors required intraoperative;The total number of rescue analgesic doses required in 24 h postoperative, postoperative analgesia using numerical rating scale NRS, postoperative analgesic duration	—

Countries

Egypt

Contacts

Public ContactRania Elmohamady Elbadrawy

Rania E Elbadrawy

raniaelmohamady@gmail.com00201003689480

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026